Birdwood Therapeutics

Ownership

Private

Therapeutic Areas

Other

Stage

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Modalities

Induced proximity medicines (likely includes small molecules and/or protein degraders based on industry context, but not explicitly stated)[1]

Birdwood Therapeutics General Information

The company is developing a high-throughput technology platform for discovering novel induced proximity medicines. No clinical results are reported yet.[1]

Contact Information

Website

https://www.sciencedirect.com/science/article/pii/S1878747924001867

Primary Industry

Biotech

Corporate Office

Redwood City, California
United States

Drug Pipeline

No pipeline data available

For full access to Birdwood Therapeutics's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Birdwood Therapeutics Funding

No funding data available

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more

To view Birdwood Therapeutics's complete valuation and funding history, request access »